Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Albany Molecular Research and Merck & Co. disclose new agents for HIV

June 15, 2011

Ferrer files MAA with EMA for tesamorelin

June 7, 2011

HIV-1 vaccine candidate rVSVIN-N4CT9-Gag1 enters phase I trial

June 2, 2011

FDA approves use of Edurant in treatment-naive adults with HIV-1

May 24, 2011

Tibotec designs novel HIV integrase inhibitors

May 12, 2011

Institute of Human Virology receives funding for HIV vaccine candidate FLSC

May 10, 2011

Bristol-Myers Squibb divulges new inhibitors of HIV integrase

May 9, 2011

AIDS Healthcare Foundation urges Gilead to halt Truvada approval in HIV prevention

April 20, 2011

FDA approves once-daily Viramune XR for use in combination for HIV-1 infection

April 6, 2011

Phase III elvitegravir trial in HIV meets primary objective

March 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...